tiprankstipranks
KRM22 Plc (GB:KRM)
LSE:KRM

KRM22 (KRM) AI Stock Analysis

Compare
2 Followers

Top Page

GB:KRM

KRM22

(LSE:KRM)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
39.00 p
▲(5.41% Upside)
Action:ReiteratedDate:12/07/25
KRM22's overall stock score is primarily impacted by its financial instability and ongoing losses, reflected in a low financial performance score. The technical analysis suggests a bearish trend, although the oversold RSI indicates potential for a rebound. The recent fundraising is a positive corporate event, providing financial flexibility and strategic growth opportunities. However, the negative valuation metrics and lack of earnings call data limit the overall score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for KRM22's risk management solutions, suggesting a robust market position and potential for future expansion.
Negative Factors
Net Losses
Ongoing net losses highlight challenges in achieving profitability, which could hinder long-term sustainability and investor confidence.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong demand for KRM22's risk management solutions, suggesting a robust market position and potential for future expansion.
Read all positive factors

KRM22 (KRM) vs. iShares MSCI United Kingdom ETF (EWC)

KRM22 Business Overview & Revenue Model

Company Description
KRM22 Plc, together with its subsidiaries, develops and sells risk management software to the financial services industry in the United Kingdom, Europe, the United States, and internationally. The company offers Risk Cockpit, which shows enterpris...
How the Company Makes Money
KRM22 generates revenue primarily through subscription-based models for its risk management software and analytics tools. Clients pay recurring fees for access to the platform, which can vary based on the tier of service and the scale of usage. Ad...

KRM22 Financial Statement Overview

Summary
KRM22 faces significant financial challenges with ongoing net losses and high leverage, risking financial stability. Despite revenue growth, profitability remains elusive due to high costs. Positive cash flow from operations is a bright spot, yet overall cash management needs improvement. Immediate actions to improve profitability and reduce leverage are essential for long-term viability.
Income Statement
35
Negative
Balance Sheet
25
Negative
Cash Flow
45
Neutral
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.12M6.77M5.27M4.27M4.13M4.59M
Gross Profit5.70M5.60M4.12M3.32M3.45M4.15M
EBITDA-497.83K350.00K-3.22M-989.00K-1.29M-3.72M
Net Income-1.65M-1.29M-4.62M-3.10M-3.33M-5.88M
Balance Sheet
Total Assets8.13M7.40M7.81M11.15M14.20M12.59M
Cash, Cash Equivalents and Short-Term Investments1.36M1.03M886.00K1.90M5.36M1.97M
Total Debt5.31M5.06M4.65M3.59M3.66M3.77M
Total Liabilities10.33M9.63M8.91M7.97M7.49M7.64M
Stockholders Equity-2.20M-2.23M-1.10M3.18M6.71M4.95M
Cash Flow
Free Cash Flow1.80M268.00K-2.00M-2.97M-802.00K-1.90M
Operating Cash Flow1.80M1.42M-879.00K-2.12M-47.00K-942.00K
Investing Cash Flow-1.06M-1.16M-1.16M-848.00K-755.00K-961.00K
Financing Cash Flow-3.00K-122.00K1.04M-535.00K4.19M2.84M

KRM22 Technical Analysis

Technical Analysis Sentiment
Negative
Last Price37.00
Price Trends
50DMA
36.79
Negative
100DMA
38.63
Negative
200DMA
39.61
Negative
Market Momentum
MACD
-0.40
Positive
RSI
3.04
Positive
STOCH
56.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KRM, the sentiment is Negative. The current price of 37 is above the 20-day moving average (MA) of 36.30, above the 50-day MA of 36.79, and below the 200-day MA of 39.61, indicating a bearish trend. The MACD of -0.40 indicates Positive momentum. The RSI at 3.04 is Positive, neither overbought nor oversold. The STOCH value of 56.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:KRM.

KRM22 Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
£57.38M7.3510.95%9.90%37.20%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
52
Neutral
£14.96M-2.82-16.69%30.40%23.48%
48
Neutral
£21.06M-2.0074.44%15.59%54.47%
44
Neutral
-1.48-47.36%3.45%
42
Neutral
£4.28M-7.39-140.34%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:KRM
KRM22
35.50
9.50
36.54%
GB:BLU
Blue Star Capital
9.00
1.50
20.00%
GB:EMVC
NetScientific
53.50
12.50
30.49%
GB:VLE
Volvere
2,620.00
720.00
37.89%
GB:KR1
KR1
15.63
-22.38
-58.88%
GB:RNEW
Ecofin U.S. Renewables Infrastructure Trust Plc
0.19
-0.09
-31.43%

KRM22 Corporate Events

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
KRM22 Boosts ARR and Strengthens Balance Sheet After £9.2m Fundraise
Positive
Jan 29, 2026
KRM22 reported that for the year to 31 December 2025 it achieved annual recurring revenue of £7.6m, up 19% at constant exchange rates, driven largely by £1.6m of new contracted ARR from cross-sales and price increases across its Risk Man...
Business Operations and StrategyExecutive/Board Changes
KRM22 Strengthens Board with Appointment of Fintech Veteran Justin Llewellyn-Jones
Positive
Jan 7, 2026
KRM22 has appointed seasoned fintech executive Justin Llewellyn-Jones as a Non-Executive Director, effective 7 January 2026, adding more than 30 years of experience across multi-asset trading, product development and operational strategy in future...
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
KRM22 Issues New Shares to Settle Acquisition Payment
Neutral
Nov 11, 2025
KRM22 plc has issued 46,729 new ordinary shares to partially satisfy deferred consideration for its acquisition of Object+. This move aims to conserve cash within the company while maintaining its financial commitments. The new shares, representin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025